LEGN: Legend Biotech Corporation - ADR Company Profile & Statistics

Legend Biotech Corporation - ADR Profile

About

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.

Info & Links

CEO

Ying Huang

Headquarters

2101 COTTONTAIL LANE
SOMERSET, NJ 08873, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

2,965

Legend Biotech Corporation - ADR Statistics

Valuation Measures

Market Capitalization²

3.54B

Enterprise Value

2.96B

Enterprise Value/EBITDA(ttm)

-10.86

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.42

Price to Book(mrq)

3.51

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

60.59%

Operating Margin(ttm)

-21.67%

Profit Margin(ttm)

-31.38%

Return on Equity(ttm)

-21.93%

Return on Invested Capital(ttm)

-23.37%

Return on Assets(ttm)

-13.21%

Income Statement

Revenue(ttm)

1.03B

Revenue Per Share(ttm)

5.56

Gross Profit(ttm)

620.80M

EBITDA(ttm)³

-272.40M

Net Income Available to Common(ttm)

-296.80M

Diluted EPS(ttm)

-0.80

Share Statistics

Beta (5Y Monthly)

0.08

52-Week Change

-39.26%

S&P 500 52-Week Change

21.98%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

184.94M

Dividend Yield

0.00%

Float⁴

184.92M

% Held by Insiders

0.02%

% Held by Institutions

70.89%

Balance Sheet

Total Cash(mrq)

948.60M

Total Cash Per Share(mrq)

5.13

Total Debt(mrq)

319.10M

Total Debt/Equity(mrq)

31.84%

Current Ratio(mrq)

1.96%

Quick Ratio(mrq)

1.91%

Book Value Per Share(mrq)

5.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.54

Free Cash Flow(ytd)

-128.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

LEGN

Legend Biotech Corporation - ADR